Stakeholder perspectives: current and potential benefits
Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…
CertaraMay 26, 2021
Strengths and opportunities for HTAs and market access in Europe through case studies
Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…
CertaraMay 26, 2021
Similarities and differences between SNDS and other claim databases
Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…
CertaraMay 25, 2021
Overview of SNDS and the key working practices to access the database and ongoing SNDS developments
Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…
CertaraMay 25, 2021
Early Engagement with HTA Bodies
In-depth guide to successful early HTA engagement.
CertaraMay 10, 2021
Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)
Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)
Watch this presentation to learn • Overview of the SNDS and the key working practices…
CertaraMay 7, 2021
Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States
Authors: Joseph McGuirk, Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang, Genovefa A. Papanicolaou…
CertaraApril 8, 2021
Legislators: Bring all stakeholders to the table to lower drug costs
BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…
CertaraMarch 30, 2021
Strategic Evidence & Value Communication Symposium
Join us on Wednesday, April 21, 2021, from12:00 PM – 2:00 PM EDT for Certara’s…
CertaraMarch 26, 2021
Getting Gene Therapies to Patients
This blog discusses the challenges that drug developers face in getting patients access to cell…
CertaraFebruary 16, 2021
